Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedrich Hahn

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 9, 2019
Visible-Light-Driven C-H Oxidation of Cyclic Tertiary Amines: Access to Synthetic Strychnos Alkaloids with Antiviral ActivityAnton A Guryev, Friedrich Hahn, Manfred Marschall, et al.
Viruses|May 28, 2022
The Oligomeric Assemblies of Cytomegalovirus Core Nuclear Egress Proteins Are Associated with Host Kinases and Show Sensitivity to Antiviral Kinase InhibitorsJintawee Kicuntod, Sigrun Häge, Friedrich Hahn, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 3, 2021
Anti-SARS-CoV-2 Inhibitory Profile of New Quinoline Compounds in Cell Culture-Based Infection ModelsLars Herrmann, Friedrich Hahn, Christina Wangen, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 19, 2022
Anti-SARS-CoV-2 Inhibitory Profile of New Quinoline Compounds in Cell Culture-Based Infection ModelsLars Herrmann, Friedrich Hahn, Christina Wangen, et al.
Placenta|July 23, 2021
A placental specific miRNA miR-517a-3p exerts anti-human cytomegalovirus activityStuart T Hamilton, Friedrich Hahn, Eric Sonntag, et al.
International Journal of Molecular Sciences|March 28, 2026
Identification of a New Phosphorylated Host Interactor of the Epstein-Barr Virus (EBV) Kinase BGLF4 Suggests Key Points for EBV-Specific Antiviral Drug TargetingMelanie Kögler, Christina Wangen, Alena Hammerschmitt, et al.
Plos One|September 10, 2020
High accuracy gene expression profiling of sorted cell subpopulations from breast cancer PDX model tissueWarren Porter, Eileen Snowden, Friedrich Hahn, et al.
Antiviral Research|September 15, 2019
Artesunate derivative TF27 inhibits replication and pathogenesis of an oncogenic avian alphaherpesvirusLuca D Bertzbach, Andelé M Conradie, Friedrich Hahn, et al.
Pharmaceutics|January 21, 2023
The Trimeric Artesunate Analog TF27, a Broadly Acting Anti-Infective Model Drug, Exerts Pronounced Anti-SARS-CoV-2 Activity Spanning Variants and Host Cell TypesFriedrich Hahn, Christina Wangen, Sigrun Häge, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
New Assay Systems to Characterize the Broad-Spectrum Antiherpesviral and Non-Herpesviral Activity of Cyclin-Dependent Kinase (CDK) 8 InhibitorsDebora Obergfäll, Friedrich Hahn, Jintawee Kicuntod, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 9, 2019
Visible-Light-Driven C-H Oxidation of Cyclic Tertiary Amines: Access to Synthetic Strychnos Alkaloids with Antiviral ActivityAnton A Guryev, Friedrich Hahn, Manfred Marschall, et al.
Viruses|May 28, 2022
The Oligomeric Assemblies of Cytomegalovirus Core Nuclear Egress Proteins Are Associated with Host Kinases and Show Sensitivity to Antiviral Kinase InhibitorsJintawee Kicuntod, Sigrun Häge, Friedrich Hahn, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 3, 2021
Anti-SARS-CoV-2 Inhibitory Profile of New Quinoline Compounds in Cell Culture-Based Infection ModelsLars Herrmann, Friedrich Hahn, Christina Wangen, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 19, 2022
Anti-SARS-CoV-2 Inhibitory Profile of New Quinoline Compounds in Cell Culture-Based Infection ModelsLars Herrmann, Friedrich Hahn, Christina Wangen, et al.
Placenta|July 23, 2021
A placental specific miRNA miR-517a-3p exerts anti-human cytomegalovirus activityStuart T Hamilton, Friedrich Hahn, Eric Sonntag, et al.
International Journal of Molecular Sciences|March 28, 2026
Identification of a New Phosphorylated Host Interactor of the Epstein-Barr Virus (EBV) Kinase BGLF4 Suggests Key Points for EBV-Specific Antiviral Drug TargetingMelanie Kögler, Christina Wangen, Alena Hammerschmitt, et al.
Plos One|September 10, 2020
High accuracy gene expression profiling of sorted cell subpopulations from breast cancer PDX model tissueWarren Porter, Eileen Snowden, Friedrich Hahn, et al.
Antiviral Research|September 15, 2019
Artesunate derivative TF27 inhibits replication and pathogenesis of an oncogenic avian alphaherpesvirusLuca D Bertzbach, Andelé M Conradie, Friedrich Hahn, et al.
Pharmaceutics|January 21, 2023
The Trimeric Artesunate Analog TF27, a Broadly Acting Anti-Infective Model Drug, Exerts Pronounced Anti-SARS-CoV-2 Activity Spanning Variants and Host Cell TypesFriedrich Hahn, Christina Wangen, Sigrun Häge, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
New Assay Systems to Characterize the Broad-Spectrum Antiherpesviral and Non-Herpesviral Activity of Cyclin-Dependent Kinase (CDK) 8 InhibitorsDebora Obergfäll, Friedrich Hahn, Jintawee Kicuntod, et al.
Pageof 6